Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[L-MTP-PE--a potential antineoplastic agent]

K Dzierzbicka1, M Gozdowska, A M Kołodziejczyk

  • 1Katedra Chemii Organicznej, Politechniki Gdańskiej w Gdańsku.

Postepy Higieny I Medycyny Doswiadczalnej
|January 1, 1997
PubMed
Summary

Muramyl tripeptide phosphatidylethanolamine (MTP-PE) liposomes target macrophages to combat tumors. This immunotherapy is in clinical trials for osteosarcoma and melanoma, potentially improving cure rates when used with other cancer treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Developments in the synthesis and biological activity of glycyl-L-histydyl- L-lysine derivatives.

Current medicinal chemistry·2013
Same author

Vasotocinergic and isotocinergic systems in the gilthead sea bream (Sparus aurata): an osmoregulatory story.

Comparative biochemistry and physiology. Part A, Molecular & integrative physiology·2013
Same author

Nanomechanical sensing of the endothelial cell response to anti-inflammatory action of 1-methylnicotinamide chloride.

International journal of nanomedicine·2013
Same author

Novel approaches in the synthesis of batracylin and its analogs: rebirth of an old player?

Current medicinal chemistry·2012
Same author

Recent developments in the synthesis and biological activity of muramylpeptides.

Current medicinal chemistry·2011
Same author

The chemistry of mycophenolic acid--synthesis and modifications towards desired biological activity.

Current medicinal chemistry·2010

Area of Science:

  • Immunology
  • Pharmacology
  • Oncology

Background:

  • Muramyl tripeptide phosphatidylethanolamine (MTP-PE) is a synthetic muramyl dipeptide analog.
  • MTP-PE activates monocytes and macrophages to eliminate tumor cells in vitro and in vivo.

Purpose of the Study:

  • To evaluate the efficacy of MTP-PE encapsulated in multilamellar liposomes (L-MTP-PE) for cancer treatment.
  • To assess L-MTP-PE as a potential therapeutic agent in clinical trials.

Main Methods:

  • Encapsulation of MTP-PE into multilamellar liposomes (L-MTP-PE) for targeted delivery.
  • Intravenous (IV) infusion of L-MTP-PE for in vivo macrophage targeting.
  • Clinical trials in patients with recurrent osteosarcoma and melanoma.

Main Results:

  • L-MTP-PE is the only form of MTP-PE currently approved for clinical trials.
  • Ongoing clinical trials are investigating L-MTP-PE in patients with osteosarcoma and melanoma.

Conclusions:

  • L-MTP-PE demonstrates potential as an immunotherapeutic agent for cancer.
  • Combination therapy with L-MTP-PE and other anticancer agents may enhance long-term cure rates for osteosarcoma and melanoma.

Related Experiment Videos